# SentinelOne, Inc.: financial statements, quarterly

S · NYSE · CIK 1583708 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/s.md) · [Financials](/companies/s/financials.md) · [Filings](/companies/s/filings.md) · [Insiders](/companies/s/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/s/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [164](/filings/0001583708-24-000125.md) | [174 d](/filings/0001583708-26-000020.md) | [186](/filings/0001583708-25-000106.md) | [199](/filings/0001583708-25-000148.md) | [211](/filings/0001583708-25-000159.md) | [226 d](/filings/0001583708-26-000020.md) | [229](/filings/0001583708-26-000041.md) | [242](/filings/0001583708-26-000055.md) | [259](/filings/0001583708-25-000159.md) | [271 d](/filings/0001583708-26-000020.md) | [277](/filings/0001583708-26-000041.md) | [292](/filings/0001583708-26-000055.md) |
| Cost of revenue | $m | [43.8](/filings/0001583708-24-000125.md) | [48.3 d](/filings/0001583708-26-000020.md) | [50.1](/filings/0001583708-25-000106.md) | [50.7](/filings/0001583708-25-000148.md) | [53.3](/filings/0001583708-25-000159.md) | [57.0 d](/filings/0001583708-26-000020.md) | [56.5](/filings/0001583708-26-000041.md) | [60.5](/filings/0001583708-26-000055.md) | [67.9](/filings/0001583708-25-000159.md) | [74.3 d](/filings/0001583708-26-000020.md) | [78.0](/filings/0001583708-26-000041.md) | [81.6](/filings/0001583708-26-000055.md) |
| Gross profit | $m | [120](/filings/0001583708-24-000125.md) | [126 d](/filings/0001583708-26-000020.md) | [136](/filings/0001583708-25-000106.md) | [148](/filings/0001583708-25-000148.md) | [157](/filings/0001583708-25-000159.md) | [169 d](/filings/0001583708-26-000020.md) | [172](/filings/0001583708-26-000041.md) | [182](/filings/0001583708-26-000055.md) | [191](/filings/0001583708-25-000159.md) | [197 d](/filings/0001583708-26-000020.md) | [199](/filings/0001583708-26-000041.md) | [210](/filings/0001583708-26-000055.md) |
| Research and development | $m | [52.3](/filings/0001583708-24-000125.md) | [56.4 d](/filings/0001583708-26-000020.md) | [58.3](/filings/0001583708-25-000106.md) | [63.6](/filings/0001583708-25-000148.md) | [70.5](/filings/0001583708-25-000159.md) | [74.6 d](/filings/0001583708-26-000020.md) | [72.3](/filings/0001583708-26-000041.md) | [79.1](/filings/0001583708-26-000055.md) | [83.1](/filings/0001583708-25-000159.md) | [89.4 d](/filings/0001583708-26-000020.md) | [95.8](/filings/0001583708-26-000041.md) | [96.9](/filings/0001583708-26-000055.md) |
| Operating income | $m | [(81.5)](/filings/0001583708-24-000125.md) | [(81.2) d](/filings/0001583708-26-000020.md) | [(80.6)](/filings/0001583708-25-000106.md) | [(79.4)](/filings/0001583708-25-000148.md) | [(89.1)](/filings/0001583708-25-000159.md) | [(80.3) d](/filings/0001583708-26-000020.md) | [(87.5)](/filings/0001583708-26-000041.md) | [(80.6)](/filings/0001583708-26-000055.md) | [(73.3)](/filings/0001583708-25-000159.md) | [(79.9) d](/filings/0001583708-26-000020.md) | [(79.7)](/filings/0001583708-26-000041.md) | [(90.8)](/filings/0001583708-26-000055.md) |
| Interest expense | $m | [0.0](/filings/0001583708-23-000054.md) | [0.0 d](/filings/0001583708-24-000016.md) | [0.0](/filings/0001583708-24-000043.md) | [0.0](/filings/0001583708-24-000074.md) | [0.0](/filings/0001583708-24-000125.md) | [0.1 d](/filings/0001583708-25-000051.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.3](/filings/0001583708-24-000125.md) | [2.0 d](/filings/0001583708-26-000020.md) | [1.5](/filings/0001583708-25-000106.md) | [2.2](/filings/0001583708-25-000148.md) | [1.5](/filings/0001583708-25-000159.md) | [1.6 d](/filings/0001583708-26-000020.md) | [133](/filings/0001583708-26-000041.md) | [3.3](/filings/0001583708-26-000055.md) | [(3.2)](/filings/0001583708-25-000159.md) | [37.4 d](/filings/0001583708-26-000020.md) | [5.8](/filings/0001583708-26-000041.md) | [6.4](/filings/0001583708-26-000055.md) |
| Net income | $m | [(70.3)](/filings/0001583708-24-000125.md) | [(72.0) d](/filings/0001583708-26-000020.md) | [(70.1)](/filings/0001583708-25-000106.md) | [(69.2)](/filings/0001583708-25-000148.md) | [(78.4)](/filings/0001583708-25-000159.md) | [(70.8) d](/filings/0001583708-26-000020.md) | [(208)](/filings/0001583708-26-000041.md) | [(72.0)](/filings/0001583708-26-000055.md) | [(60.3)](/filings/0001583708-25-000159.md) | [(110) d](/filings/0001583708-26-000020.md) | [(76.2)](/filings/0001583708-26-000041.md) | [(93.4)](/filings/0001583708-26-000055.md) |
| Diluted EPS | $ per share | [(0.24)](/filings/0001583708-24-000125.md) | not reported | [(0.23)](/filings/0001583708-25-000106.md) | [(0.22)](/filings/0001583708-25-000148.md) | [(0.25)](/filings/0001583708-25-000159.md) | not reported | [(0.63)](/filings/0001583708-26-000041.md) | [(0.22)](/filings/0001583708-26-000055.md) | [(0.18)](/filings/0001583708-25-000159.md) | not reported | [(0.23)](/filings/0001583708-26-000041.md) | [(0.27)](/filings/0001583708-26-000055.md) |
| Basic EPS | $ per share | [(0.24)](/filings/0001583708-24-000125.md) | not reported | [(0.23)](/filings/0001583708-25-000106.md) | [(0.22)](/filings/0001583708-25-000148.md) | [(0.25)](/filings/0001583708-25-000159.md) | not reported | [(0.63)](/filings/0001583708-26-000041.md) | [(0.22)](/filings/0001583708-26-000055.md) | [(0.18)](/filings/0001583708-25-000159.md) | not reported | [(0.23)](/filings/0001583708-26-000041.md) | [(0.27)](/filings/0001583708-26-000055.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [127](/filings/0001583708-23-000054.md) | [257](/filings/0001583708-25-000051.md) | [199](/filings/0001583708-24-000043.md) | [278](/filings/0001583708-25-000148.md) | [236](/filings/0001583708-24-000125.md) | [187](/filings/0001583708-26-000020.md) | [189](/filings/0001583708-25-000106.md) | [278](/filings/0001583708-25-000148.md) | [150](/filings/0001583708-25-000159.md) | [170](/filings/0001583708-26-000055.md) | [153](/filings/0001583708-26-000041.md) | [201](/filings/0001583708-26-000055.md) |
| Current assets | $m | [1,069](/filings/0001583708-23-000054.md) | [1,297](/filings/0001583708-25-000051.md) | [1,066](/filings/0001583708-24-000043.md) | [1,021](/filings/0001583708-24-000074.md) | [991](/filings/0001583708-24-000125.md) | [1,070](/filings/0001583708-26-000020.md) | [1,031](/filings/0001583708-25-000106.md) | [1,093](/filings/0001583708-25-000148.md) | [957](/filings/0001583708-25-000159.md) | [1,051](/filings/0001583708-26-000055.md) | [966](/filings/0001583708-26-000041.md) | [998](/filings/0001583708-26-000055.md) |
| Total assets | $m | [2,196](/filings/0001583708-23-000054.md) | [2,321](/filings/0001583708-25-000051.md) | [2,310](/filings/0001583708-24-000043.md) | [2,347](/filings/0001583708-24-000074.md) | [2,367](/filings/0001583708-24-000125.md) | [2,407](/filings/0001583708-26-000020.md) | [2,384](/filings/0001583708-25-000106.md) | [2,350](/filings/0001583708-25-000148.md) | [2,432](/filings/0001583708-25-000159.md) | [2,438](/filings/0001583708-26-000055.md) | [2,356](/filings/0001583708-26-000041.md) | [2,381](/filings/0001583708-26-000055.md) |
| Current liabilities | $m | [499](/filings/0001583708-23-000054.md) | [590](/filings/0001583708-25-000051.md) | [566](/filings/0001583708-24-000043.md) | [588](/filings/0001583708-24-000074.md) | [607](/filings/0001583708-24-000125.md) | [614](/filings/0001583708-26-000020.md) | [589](/filings/0001583708-25-000106.md) | [597](/filings/0001583708-25-000148.md) | [628](/filings/0001583708-25-000159.md) | [756](/filings/0001583708-26-000055.md) | [672](/filings/0001583708-26-000041.md) | [689](/filings/0001583708-26-000055.md) |
| Total liabilities | $m | [615](/filings/0001583708-23-000054.md) | [727](/filings/0001583708-25-000051.md) | [694](/filings/0001583708-24-000043.md) | [713](/filings/0001583708-24-000074.md) | [727](/filings/0001583708-24-000125.md) | [737](/filings/0001583708-26-000020.md) | [837](/filings/0001583708-25-000106.md) | [843](/filings/0001583708-25-000148.md) | [882](/filings/0001583708-25-000159.md) | [1,001](/filings/0001583708-26-000055.md) | [918](/filings/0001583708-26-000041.md) | [933](/filings/0001583708-26-000055.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,581](/filings/0001583708-24-000125.md) | [1,594](/filings/0001583708-26-000020.md) | [1,616](/filings/0001583708-25-000148.md) | [1,634](/filings/0001583708-25-000159.md) | [1,640](/filings/0001583708-25-000159.md) | [1,669](/filings/0001583708-26-000055.md) | [1,547](/filings/0001583708-26-000055.md) | [1,508](/filings/0001583708-26-000055.md) | [1,550](/filings/0001583708-25-000159.md) | [1,437](/filings/0001583708-26-000055.md) | [1,438](/filings/0001583708-26-000055.md) | [1,449](/filings/0001583708-26-000055.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(22.2) d](/filings/0001583708-24-000125.md) | [(6.2) d](/filings/0001583708-26-000020.md) | [42.0](/filings/0001583708-25-000106.md) | [2.3 d](/filings/0001583708-25-000148.md) | [(7.2) d](/filings/0001583708-25-000159.md) | [(3.4) d](/filings/0001583708-26-000020.md) | [52.3](/filings/0001583708-26-000041.md) | [(1.0) d](/filings/0001583708-26-000055.md) | [21.0 d](/filings/0001583708-25-000159.md) | [4.4 d](/filings/0001583708-26-000020.md) | [38.5](/filings/0001583708-26-000041.md) | [(6.5) d](/filings/0001583708-26-000055.md) |
| Capital expenditure | $m | [0.6 d](/filings/0001583708-24-000125.md) | [0.2 d](/filings/0001583708-26-000020.md) | [0.9](/filings/0001583708-25-000106.md) | [0.6 d](/filings/0001583708-25-000148.md) | [0.2 d](/filings/0001583708-25-000159.md) | [0.2 d](/filings/0001583708-26-000020.md) | [0.1](/filings/0001583708-26-000041.md) | [0.3 d](/filings/0001583708-26-000055.md) | [0.1 d](/filings/0001583708-25-000159.md) | [0.2 d](/filings/0001583708-26-000020.md) | [0.4](/filings/0001583708-26-000041.md) | [0.1 d](/filings/0001583708-26-000055.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001583708-25-000159.md) | [0.0 d](/filings/0001583708-26-000020.md) | not reported | not reported | [49.2 d](/filings/0001583708-25-000159.md) | [98.1 d](/filings/0001583708-26-000020.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-31) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [281](/filings/0001583708-23-000054.md) | [288](/filings/0001583708-24-000043.md) | [293](/filings/0001583708-24-000074.md) | [297](/filings/0001583708-24-000125.md) | [310](/filings/0001583708-25-000106.md) | [313](/filings/0001583708-25-000148.md) | [317](/filings/0001583708-25-000159.md) | [328](/filings/0001583708-26-000041.md) | [331](/filings/0001583708-26-000055.md) | [333](/filings/0001583708-25-000159.md) | [337](/filings/0001583708-26-000041.md) | [342](/filings/0001583708-26-000055.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.